Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 23, 2011 - Issue 1
94
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Attempts to counteract phosgene-induced acute lung injury by instant high-dose aerosol exposure to hexamethylenetetramine, cysteine or glutathione

&
Pages 58-64 | Received 14 Oct 2010, Accepted 17 Nov 2010, Published online: 12 Jan 2011

References

  • Allison RC. 1991. Initial treatment of pulmonary edema: a physiological approach. Am J Med Sci 302:385–391.
  • Anjilvel S, Asgharian B. 1995. A multiple-path model of particle deposition in the rat lung. Fundam Appl Toxicol 28:41–50.
  • Benoit A, Ducas J, Girling L, Schick U, Prewitt RM. 1985. Acute cardiopulmonary effects of nitroglycerin in canine oleic acid pulmonary edema. Anesthesiology 62:754–758.
  • Berthiaume Y. 1998. Mechanisms of edema clearance. In: Pulmonary Edema, Weir EK, Reeves JT, Armonk, NY (Eds.), Futura, pp. 77–94.
  • Berthiaume Y, Folkesson HG, Matthay MA. 2002. Lung edema clearance: 20 years of progress: invited review: alveolar edema fluid clearance in the injured lung. J Appl Physiol 93:2207–2213.
  • Berthiaume Y, Lesur O, Dagenais A. 1999. Treatment of adult respiratory distress syndrome: plea for rescue therapy of the alveolar epithelium. Thorax 54:150–160.
  • Buhl R, Vogelmeier C, Critenden M, Hubbard RC, Hoyt RF Jr, Wilson EM, Cantin AM, Crystal RG. 1990. Augmentation of glutathione in the fluid lining the epithelium of the lower respiratory tract by directly administering glutathione aerosol. Proc Natl Acad Sci USA 87:4063–4067.
  • Cantin A, S North RC, Hubbard, Crystal RG. 1987. Normal alveolar epithelial lining fluid contains high levels of glutathione. J Appl Physiol 63:152–157.
  • Chen HI. 1995. Hemodynamic mechanisms of neurogenic pulmonary edema. Biol Signals 4:186–192.
  • Chen HL, Hai CX, Liang X, Zhang XD, Liu R, Qin XJ. 2009. Correlation between sPLA2-IIA and phosgene-induced rat acute lung injury. Inhal Toxicol 21:374–380.
  • Diller WF. 1980. The methenamine misunderstanding in the therapy of phosgene poisoning. Arch Toxicol 46:199–206.
  • Directive 86/609/EEC. 1986. Guideline of the Council dated November 24, 1986 on the Reconciliation of Legal and Administrative Regulations of the Member Countries for the Protection of Animals used for Studies and other Scientific Purposes. J European Commun, Legal Specifications L358, 29:1–28.
  • Duniho SM, Martin J, Forster JS, Cascio MB, Moran TS, Carpin LB, Sciuto AM. 2002. Acute changes in lung histopathology and bronchoalveolar lavage parameters in mice exposed to the choking agent gas phosgene. Toxicol Pathol 30:339–349.
  • Frosolono MF. 1985. Prophylactic and antidotal effects of hexamethylenetetramine against phosgene poisoning in rabbits. Toxicol Ind Health 1:101–116.
  • Gould NS, Day BJ. 2010. Targeting maladaptive glutathione responses in lung disease. Biochem Pharmacol.
  • Grainge C, Rice P. 2010. Management of phosgene-induced acute lung injury. Clin Toxicol (Phila) 48:497–508.
  • Hatch G, Kodavanti U, Crissman K, Slade R, Costa D. 2001. An ‘injury-time integral’ model for extrapolating from acute to chronic effects of phosgene. Toxicol Ind Health 17:285–293.
  • Hobbs MJ, Butterworth M, Cohen GM, Upshall DG. 1993. Structure-activity relationships of cysteine esters and their effects on thiol levels in rat lung in vitro. Biochem Pharmacol 45:1605–1612.
  • Ivanhoe F, Meyers FH. 1964. Phosgene poisoning as an example of neuroparalytic acute pulmonary edema: The sympathetic vasomotor reflex involved. Dis Chest 46:211–218.
  • Ji L, Liu R, Zhang XD, Chen HL, Bai H, Wang X, Zhao HL, Liang X, Hai CX. 2010. N-acetylcysteine attenuates phosgene-induced acute lung injury via up-regulation of Nrf2 expression. Inhal Toxicol 22:535–542.
  • Kodavanti UP, Costa DL, Giri SN, Starcher B, Hatch GE. 1997. Pulmonary structural and extracellular matrix alterations in Fischer 344 rats following subchronic phosgene exposure. Fundam Appl Toxicol 37:54–63.
  • Lailey AF, Hill L, Lawston IW, Stanton D, Upshall DG. 1991. Protection by cysteine esters against chemically induced pulmonary oedema. Biochem Pharmacol 42 Suppl:S47–S54.
  • Matthay MA, Clerici C, Saumon G. 2002a. Invited review: Active fluid clearance from the distal air spaces of the lung. J Appl Physiol 93:1533–1541.
  • Matthay MA, Folkesson HG, Clerici C. 2002b. Lung epithelial fluid transport and the resolution of pulmonary edema. Physiol Rev 82:569–600.
  • Mauderly JL. 1989. Effect of inhaled toxicants on pulmonary function. In: Concepts in Inhalation Toxicology, RO McClellan, and RF Henderson (eds). Hemisphere Publishing Corporation, New York, pp. 347–401.
  • OECD. 2009. Organization for Economic Cooperation and Development (OECD) -Environment, Health and Safety Publications, Series on Testing and Assessment No. 39: Guidance Document for Acute Inhalation Toxicity Testing, [ENV/JM/MONO 28; July 21, 2009]. Available at: http://oberon.sourceoecd.org.
  • Parker JC, Parker RE, Granger DN, Taylor AE. 1981. Vascular permeability and transvascular fluid and protein transport in the dog lung. Circ Res 48:549–561.
  • Pauluhn J, Mohr U. 2000. Inhalation studies in laboratory animals–current concepts and alternatives. Toxicol Pathol 28:734–753.
  • Pauluhn J. 2000. Acute inhalation toxicity of polymeric diphenyl-methane 4,4’-diisocyanate in rats: time course of changes in bronchoalveolar lavage. Arch Toxicol 74:257–269.
  • Pauluhn J. 2002. Short-term inhalation toxicity of polyisocyanate aerosols in rats: comparative assessment of irritant-threshold concentrations by bronchoalveolar lavage. Inhal Toxicol 14:287–301.
  • Pauluhn J. 2004. Pulmonary irritant potency of polyisocyanate aerosols in rats: comparative assessment of irritant threshold concentrations by bronchoalveolar lavage. J Appl Toxicol 24:231–247.
  • Pauluhn J. 2005. Retrospective analysis of acute inhalation toxicity studies: comparison of actual concentrations by filter and cascade impactor analyses. Regul Toxicol Pharmacol 42:236–244.
  • Pauluhn J. 2006a. Acute nose-only exposure of rats to phosgene. Part I: concentration x time dependence of LC50s, nonlethal-threshold concentrations, and analysis of breathing patterns. Inhal Toxicol 18:423–435.
  • Pauluhn J. 2006b. Acute nose-only exposure of rats to phosgene. Part II. Concentration x time dependence of changes in bronchoalveolar lavage during a follow-up period of 3 months. Inhal Toxicol 18:595–607.
  • Pauluhn J, Thiel A. 2007. A simple approach to validation of directed-flow nose-only inhalation chambers. J Appl Toxicol 27:160–167.
  • Pauluhn J, Carson A, Costa DL, Gordon T, Kodavanti U, Last JA, Matthay MA, Pinkerton KE, Sciuto AM. 2007. Workshop summary: phosgene-induced pulmonary toxicity revisited: appraisal of early and late markers of pulmonary injury from animal models with emphasis on human significance. Inhal Toxicol 19:789–810.
  • Pauluhn J, 2010. Acute Nose-only Inhalation Exposure of Rats to Di- and Triphosgene relative to Phosgene. Inhal Toxicol. (submitted for publication).
  • Potts AM, Simon FP, Gerard RW. 1949. The mechanism of action of phosgene and diphosgene. Arch Biochem 24:329–337.
  • Rahman I, MacNee W. 2000. Oxidative stress and regulation of glutathione in lung inflammation. Eur Respir J 16:534–554.
  • RIVM (National Institute for Public Health and the Environment). 2002. Multiple Path Particle Dosimetry Model (MPPD2 v. 1.0): A Model for Human and Rat Airway Particle Dosimetry. Bilthoven, The Netherlands. RIVA Report 650010030; 2002.
  • Sarnoff SJ, Berglund E, Sarnoff LC. 1953. Neurohemodynamics of pulmonary edema. III. Estimated changes in pulmonary blood volume accompanying systemic vasoconstriction and vasodilation. J Appl Physiol 5:367–374.
  • Sciuto AM, Strickland PT, Kennedy TP, Gurtner GH. 1995. Protective effects of N-acetylcysteine treatment after phosgene exposure in rabbits. Am J Respir Crit Care Med 151:768–772.
  • Sciuto AM, Strickland PT, Kennedy TP, Guo YL, Gurtner GH. 1996. Intratracheal administration of DBcAMP attenuates edema formation in phosgene-induced acute lung injury. J Appl Physiol 80:149–157.
  • Sciuto AM. 1997. Ibuprofen treatment enhances the survival of mice following exposure to phosgene. Inhal. Toxicol. 9, 389–403.
  • Sciuto AM, Hurt HH. 2004. Therapeutic treatments of phosgene-induced lung injury. Inhal Toxicol 16:565–580.
  • Slade R, Crissman K, Norwood J, Hatch G. 1993. Comparison of antioxidant substances in bronchoalveolar lavage cells and fluid from humans, guinea pigs, and rats. Exp Lung Res 19:469–484.
  • Suntres ZE, Shek PN. 1996. Alleviation of paraquat-induced lung injury by pretreatment with bifunctional liposomes containing alpha-tocopherol and glutathione. Biochem Pharmacol 52:1515–1520.
  • van Helden HPM, van de Meent D, Oostdijk JP, Joosen MJA, vanEsch JHM, Hammer AH, Diemel RV. 2004. Protection of rats against perfluoroisobutene (PFIB)-induced pulmonary edema by curosurf and N-acetylcysteine. Inhal Toxicol 16, 549–564.
  • Wang X, Ye XL, Liu R, Chen HL, Bai H, Liang X, Zhang XD, Wang Z, Li WL, Hai CX. 2010. Antioxidant activities of oleanolic acid in vitro: possible role of Nrf2 and MAP kinases. Chem Biol Interact 184:328–337.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.